Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer

Francesco Boccardo,Dino Amadori,Pamela Guglielmini,Piero Sismondi,A. Farris,Biagio Agostara,Angelo Gambi,Giuseppina Catalano,Marina Faedi,A. Rubagotti

Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer

2010

Francesco Boccardo
Dino Amadori
Pamela Guglielmini
Piero Sismondi
A. Farris
Biagio Agostara
Angelo Gambi
Giuseppina Catalano
Marina Faedi
A. Rubagotti

Objective: Breast cancer patients with >3 involved nodes (N+) have a poor outcome. Chemotherapy (CT), alone or combined with endocrine therapy (ET) in hormone receptor (HOR)-positiv

Keywords:

Breast cancer
Immunology
Breast disease
Vinorelbine
Fluorouracil
Cancer
Epirubicin
Medicine
Cyclophosphamide
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations